Bayer introduces medication for chronic kidney disease
"The major focus of therapy in patients with chronic kidney disease and diabetes is to prevent end-stage renal disease or kidney failure. Despite therapy, these patients often progress to kidney failure.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Chronic Kidney Disease | Diabetes | Endocrinology | Pharmaceuticals | Urology & Nephrology